Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 97

1.

c-MYC inhibition impairs hypoxia response in glioblastoma multiforme.

Mongiardi MP, Savino M, Falchetti ML, Illi B, Bozzo F, Valle C, Helmer-Citterich M, Ferrè F, Nasi S, Levi A.

Oncotarget. 2016 Apr 22. doi: 10.18632/oncotarget.8921. [Epub ahead of print]

2.

Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship.

Ardighieri L, Mori L, Conzadori S, Bugatti M, Falchetti M, Donzelli CM, Ravaggi A, Odicino FE, Facchetti F.

Virchows Arch. 2016 Apr 8. [Epub ahead of print]

PMID:
27059324
3.

Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.

Brini AT, Coccè V, Ferreira LM, Giannasi C, Cossellu G, Giannì AB, Angiero F, Bonomi A, Pascucci L, Falchetti ML, Ciusani E, Bondiolotti G, Sisto F, Alessandri G, Pessina A, Farronato G.

Expert Opin Drug Deliv. 2016 Apr 5:1-10. [Epub ahead of print]

PMID:
26986001
4.

Placental morphology in pregnancies associated with pregravid obesity.

Loardi C, Falchetti M, Prefumo F, Facchetti F, Frusca T.

J Matern Fetal Neonatal Med. 2016 Aug;29(16):2611-6. doi: 10.3109/14767058.2015.1094792. Epub 2015 Nov 23.

PMID:
26595316
5.

Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.

Mongiardi MP, Savino M, Bartoli L, Beji S, Nanni S, Scagnoli F, Falchetti ML, Favia A, Farsetti A, Levi A, Nasi S, Illi B.

Sci Rep. 2015 Nov 13;5:15494. doi: 10.1038/srep15494.

6.

Placental histological patterns and uterine artery Doppler velocimetry in pregnancies complicated by early and late pre-eclampsia.

Orabona R, Donzelli CM, Falchetti M, Santoro A, Valcamonico A, Frusca T.

Ultrasound Obstet Gynecol. 2015 Oct 29. doi: 10.1002/uog.15799. [Epub ahead of print]

PMID:
26511592
7.

Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.

Pacioni S, D'Alessandris QG, Giannetti S, Morgante L, De Pascalis I, Coccè V, Bonomi A, Pascucci L, Alessandri G, Pessina A, Falchetti ML, Pallini R.

Stem Cell Res Ther. 2015 Oct 6;6:194. doi: 10.1186/s13287-015-0185-z.

8.

Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy.

Ottini L, Rizzolo P, Zanna I, Silvestri V, Saieva C, Falchetti M, Masala G, Navazio AS, Capalbo C, Bianchi S, Manoukian S, Barile M, Peterlongo P, Caligo MA, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Cini G, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2014 Dec;148(3):623-8. doi: 10.1007/s10549-014-3193-2. Epub 2014 Nov 11.

PMID:
25385181
9.

Immortalization of human adipose-derived stromal cells: production of cell lines with high growth rate, mesenchymal marker expression and capability to secrete high levels of angiogenic factors.

Balducci L, Blasi A, Saldarelli M, Soleti A, Pessina A, Bonomi A, Coccè V, Dossena M, Tosetti V, Ceserani V, Navone SE, Falchetti ML, Parati EA, Alessandri G.

Stem Cell Res Ther. 2014 May 6;5(3):63. doi: 10.1186/scrt452.

10.

Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implications.

Richetta AG, Silvestri V, Giancristoforo S, Rizzolo P, D'Epiro S, Graziano V, Mattozzi C, Navazio AS, Falchetti M, Calvieri S, Ottini L.

Oncology. 2014;86(2):104-8. doi: 10.1159/000356878. Epub 2014 Jan 18.

PMID:
24457427
11.

Male breast cancer: genetics, epigenetics, and ethical aspects.

Rizzolo P, Silvestri V, Tommasi S, Pinto R, Danza K, Falchetti M, Gulino M, Frati P, Ottini L.

Ann Oncol. 2013 Nov;24 Suppl 8:viii75-viii82. doi: 10.1093/annonc/mdt316. Review.

12.

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

Bellone S, Tassi R, Betti M, English D, Cocco E, Gasparrini S, Bortolomai I, Black JD, Todeschini P, Romani C, Ravaggi A, Bignotti E, Bandiera E, Zanotti L, Pecorelli S, Ardighieri L, Falchetti M, Donzelli C, Siegel ER, Azodi M, Silasi DA, Ratner E, Schwartz PE, Rutherford TJ, Santin AD.

Br J Cancer. 2013 Jul 23;109(2):462-71. doi: 10.1038/bjc.2013.315. Epub 2013 Jun 27.

13.

SULT1A1 gene deletion in BRCA2-associated male breast cancer: a link between genes and environmental exposures?

Palli D, Rizzolo P, Zanna I, Silvestri V, Saieva C, Falchetti M, Navazio AS, Graziano V, Masala G, Bianchi S, Russo A, Tommasi S, Ottini L.

J Cell Mol Med. 2013 May;17(5):605-7. doi: 10.1111/jcmm.12043.

14.

Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy.

Ottini L, Silvestri V, Saieva C, Rizzolo P, Zanna I, Falchetti M, Masala G, Navazio AS, Graziano V, Bianchi S, Manoukian S, Barile M, Peterlongo P, D'Amico C, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2013 Apr;138(3):861-8. doi: 10.1007/s10549-013-2459-4. Epub 2013 Mar 7.

PMID:
23468243
15.

Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.

Pessina A, Coccè V, Pascucci L, Bonomi A, Cavicchini L, Sisto F, Ferrari M, Ciusani E, Crovace A, Falchetti ML, Zicari S, Caruso A, Navone S, Marfia G, Benetti A, Ceccarelli P, Parati E, Alessandri G.

Br J Haematol. 2013 Mar;160(6):766-78. doi: 10.1111/bjh.12196. Epub 2013 Jan 7.

PMID:
23293837
16.

[Fire worship on Soratte: form prehistory to present days].

Falchetti M, Ottini L.

Med Secoli. 2013;25(2):609-36. Italian.

PMID:
25807785
17.

[Medical research through historical resources. Talking objects: a case of a parasitic perineal monstrosity].

Ottini L, Franza A, Rizzolo P, Falchetti M, Santi R, Nesi G.

Med Secoli. 2013;25(1):267-94. Italian.

PMID:
25807709
18.

Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.

Bignotti E, Zanotti L, Calza S, Falchetti M, Lonardi S, Ravaggi A, Romani C, Todeschini P, Bandiera E, Tassi RA, Facchetti F, Sartori E, Pecorelli S, Roque DM, Santin AD.

BMC Clin Pathol. 2012 Nov 14;12:22. doi: 10.1186/1472-6890-12-22.

19.

Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma.

Cenci T, Martini M, Montano N, D'Alessandris QG, Falchetti ML, Annibali D, Savino M, Bianchi F, Pierconti F, Nasi S, Pallini R, Larocca LM.

Am J Clin Pathol. 2012 Sep;138(3):390-6. doi: 10.1309/AJCPRXHNJQLO09QA.

20.

Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.

Ottini L, Silvestri V, Rizzolo P, Falchetti M, Zanna I, Saieva C, Masala G, Bianchi S, Manoukian S, Barile M, Peterlongo P, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2012 Jul;134(1):411-8. doi: 10.1007/s10549-012-2062-0. Epub 2012 Apr 18.

PMID:
22527108
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk